###
中国初级卫生保健:2018,32(11):69-70
本文二维码信息
码上扫一扫!
益气养阴活血中药复方联合西药治疗糖尿病合并高脂血症的临床研究
摘要
图/表
参考文献
相似文献
本文已被:浏览 5686次   下载 0
    
中文摘要: 目的 观察益气养阴活血中药复方联合西药治疗糖尿病合并高脂血症的临床疗效,分析益气养阴活血中药复方的作用机制。方法 选取2017年1月—2017年12月在我院内分泌科住院接受治疗的糖尿病合并高脂血症患者120例,采用随机数字表法分为对照组和治疗组,每组各60例。对照组根据患者血糖、血脂情况采取西药治疗;治疗组在对照组西药治疗的基础上加用益气养阴活血中药复方治疗,治疗周期均为21 d。结果 治疗后,两组临床总有效率、中医症候治疗总有效率、中医证候积分和血脂水平均得到改善,而治疗组临床总有效率、中医症候治疗总有效率、中医证候积分和血脂水平改善均高于对照组,差异有统计学意义(P<0.05)。结论 益气养阴活血中药复方联合西药治疗糖尿病合并高脂血症的效果显著,值得临床推广。
Abstract:OBJECTIVE To observe the clinical curative effect of Yiqi Yangyin Huoxue Chinese medicinal compound combined with western medicine in the treatment of diabetes complicated with hyperlipidemia, and to analyze the mechanism of Yiqi Yangyin Huoxue Chinese Herbal Compound. METHODS One hundred and twenty patients with diabetes mellitus complicated with hyperlipidemia treated in hospital endocrinology department of our hospital from January 2017 to December 2017 were randomly divided into control group and treatment group by random number table method. Each of 60 cases. In the control group, Western medicine was selected based on the patients' blood glucose and lipids; the treatment group was treated with the combination of Yiqi Yangyin Huoxue Chinese Herbal Medicine on the basis of western medicine treatment in the control group. The treatment period is 21 d. RESULTS After the treatment, the total effective rate of the two groups, the total effective rate of TCM syndrome treatment, the improvement of TCM syndrome scores, and the improvement of blood lipid levels were improved. The total clinical efficacy of the treatment group, the total effective rate of TCM syndrome treatment, and the TCM syndrome The scores of improvement of the waiting points and improvement of blood lipid levels were all higher than those of the control group, and the difference was statistically significant(P<0.05). CONCLUSION The therapeutic effect of Yiqi Yangyin Huoxue Chinese medicine compound combined with western medicine on diabetes mellitus complicated with hyperlipidemia is significant and worthy of clinical promotion.
文章编号:3201811026     中图分类号:R587.1    文献标志码:
基金项目:
作者单位
曲 梅①  
Author NameAffiliation
  
引用文本:


用微信扫一扫

用微信扫一扫